InvestorsHub Logo
Followers 2
Posts 281
Boards Moderated 0
Alias Born 01/30/2017

Re: None

Thursday, 01/20/2022 4:30:38 PM

Thursday, January 20, 2022 4:30:38 PM

Post# of 465090
9:30 am Using Precision Medicine in Clinical Trials to Advancing Therapeutics for both Degenerative & Rare Mitochondrial Diseases

Christopher Missling
President & Chief Executive Officer, Anavex Life Sciences Corp
Synopsis

Assessing clinical data with biomarker-correlated outcomes of ANAVEX2-73 (blarcamesine) in Alzheimer’s, Parkinson’s, and Rett Syndrome
Reviewing mechanistic analysis of involvement of mitochondrial function
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News